APA (7th ed.) Citation

Brunette, C. A., Dong, O. M., Vassy, J. L., Danowski, M. E., Alexander, N., Antwi, A. A., & Christensen, K. D. (2021). A Cost–Consequence Analysis of Preemptive <i>SLCO1B1</i> Testing for Statin Myopathy Risk Compared to Usual Care. MDPI AG.

Chicago Style (17th ed.) Citation

Brunette, Charles A., Olivia M. Dong, Jason L. Vassy, Morgan E. Danowski, Nicholas Alexander, Ashley A. Antwi, and Kurt D. Christensen. A Cost–Consequence Analysis of Preemptive <i>SLCO1B1</i> Testing for Statin Myopathy Risk Compared to Usual Care. MDPI AG, 2021.

MLA (8th ed.) Citation

Brunette, Charles A., et al. A Cost–Consequence Analysis of Preemptive <i>SLCO1B1</i> Testing for Statin Myopathy Risk Compared to Usual Care. MDPI AG, 2021.